Meeting Summary

CDC and Prevention Experts’ Meeting on Minimizing the Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) in the Community

Released: March 2006

On July 19-20, 2004, in Atlanta, Georgia, USA, the Centers for Disease Control and Prevention convened a meeting of experts representing academic medicine; local, state, and federal public health; and other federal agencies, including the U.S. Food and Drug Administration, the Federal Bureau of Prisons, and the Department of Defense. The goals of the meeting were to (1) review current knowledge regarding transmission of methicillin-resistant Staphylococcus aureus (MRSA) in the community, (2) discuss strategies for management on the individual patient and community level, and (3) identify areas where additional research is needed. A detailed summary of strategies for the clinical management of MRSA in the community, based on discussions held at this meeting, in conjunction with additional data available as of January 2006, is available in pdf format.





Date last modified: March 17, 2006
Content source: 
Division of Healthcare Quality Promotion (DHQP)
National Center for Preparedness, Detection, and Control of Infectious Diseases